|
1.
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2.
|
Chow WH, Dong LM and Devesa SS:
Epidemiology and risk factors for kidney cancer. Nat Rev Urol.
7:245–257. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Southard EB, Roff A, Fortugno T, et al:
Lead, calcium uptake, and related genetic variants in association
with renal cell carcinoma risk in a cohort of male Finnish smokers.
Cancer Epidemiol Biomarkers Prev. 21:191–201. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Wang G, Hou J, Ma L, et al: Risk factor
for clear cell renal cell carcinoma in Chinese population: a
case-control study. Cancer Epidemiol. 36:177–182. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Moore LE, Brennan P, Karami S, et al:
Glutathione S-transferase polymorphisms, cruciferous vegetable
intake and cancer risk in the Central and Eastern European Kidney
Cancer Study. Carcinogenesis. 28:1960–1964. 2007. View Article : Google Scholar
|
|
6.
|
Moore LE, Boffetta P, Karami S, et al:
Occupational trichloroethylene exposure and renal carcinoma risk:
evidence of genetic susceptibility by reductive metabolism gene
variants. Cancer Res. 70:6527–6536. 2010. View Article : Google Scholar
|
|
7.
|
Bruyère F, Hovens CM, Marson MN, et al:
VEGF polymorphisms are associated with an increasing risk of
developing renal cell carcinoma. J Urol. 184:1273–1278.
2010.PubMed/NCBI
|
|
8.
|
Hirata H, Hinoda Y, Nakajima K, et al: Wnt
antagonist gene polymorphisms and renal cancer. Cancer.
115:4488–4503. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Andreotti G, Boffetta P, Rosenberg PS, et
al: Variants in blood pressure genes and the risk of renal cell
carcinoma. Carcinogenesis. 31:614–620. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Longuemaux S, Deloménie C, Gallou C, et
al: Candidate genetic modifiers of individual susceptibility to
renal cell carcinoma: a study of polymorphic human
xenobiotic-metabolizing enzymes. Cancer Res. 59:2903–2908.
1999.
|
|
11.
|
Aben KK, Luth TK, Janssen-Heijnen ML,
Mulders PF, Kiemeney LA and van Spronsen DJ: No improvement in
renal cell carcinoma survival: a population-based study in the
Netherlands. Eur J Cancer. 44:1701–1709. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Sun M, Shariat SF, Cheng C, et al:
Prognostic factors and predictive models in renal cell carcinoma: a
contemporary review. Eur Urol. 60:644–661. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Lughezzani G, Karakiewicz PI, Bigot P, et
al: The prognostic value of erythrocyte polyamines in the
preoperative evaluation of patients with renal cell carcinoma. Eur
J Cancer. 46:1927–1935. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Doberstein K, Wieland A, Lee SB, et al:
L1-CAM expression in ccRCC correlates with shorter patients
survival times and confers chemoresistance in renal cell carcinoma
cells. Carcinogenesis. 32:262–270. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Kojima T, Shimazui T, Horie R, et al:
FOXO1 and TCF7L2 genes involved in metastasis and poor prognosis in
clear cell renal cell carcinoma. Genes Chromosomes Cancer.
49:379–389. 2010.PubMed/NCBI
|
|
16.
|
Li X, Tan X, Yu Y, et al: D9S168
microsatellite alteration predicts a poor prognosis in patients
with clear cell renal cell carcinoma and correlates with the
down-regulation of protein tyrosine phosphatase receptor delta.
Cancer. 117:4201–4211. 2011. View Article : Google Scholar
|
|
17.
|
Kleinrath T, Gassner C, Lackner P,
Thurnher M and Ramoner R: Interleukin-4 promoter polymorphisms: a
genetic prognostic factor for survival in metastatic renal cell
carcinoma. J Clin Oncol. 25:845–851. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Hirata H, Hinoda Y, Kikuno N, et al: MDM2
SNP309 polymorphism as risk factor for susceptibility and poor
prognosis in renal cell carcinoma. Clin Cancer Res. 13:4123–4129.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Lin J, Horikawa Y, Tamboli P, Clague J,
Wood CG and Wu X: Genetic variations in microRNA-related genes are
associated with survival and recurrence in patients with renal cell
carcinoma. Carcinogenesis. 31:1805–1812. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Purdue MP, Johansson M, Zelenika D, et al:
Genome-wide association study of renal cell carcinoma identifies
two susceptibility loci on 2p21 and 11q13.3. Nat Genet. 43:60–65.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Schödel J, Bardella C, Sciesielski LK, et
al: Common genetic variants at the 11q13.3 renal cancer
susceptibility locus influence binding of HIF to an enhancer of
cyclin D1 expression. Nat Genet. 44:420–425. 2012.PubMed/NCBI
|
|
22.
|
Chang W, Ma L, Lin L, et al:
Identification of novel hub genes associated with liver metastasis
of gastric cancer. Int J Cancer. 125:2844–2853. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Wu X, Scelo G, Purdue MP, et al: A
genome-wide association study identifies a novel susceptibility
locus for renal cell carcinoma on 12p11.23. Hum Mol Genet.
21:456–462. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Han SS, Yeager M, Moore LE, et al: The
chromosome 2p21 region harbors a complex genetic architecture for
association with risk for renal cell carcinoma. Hum Mol Genet.
21:1190–1200. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Cao Q, Qin C, Ju X, et al: Chromosome
11q13.3 variant modifies renal cell cancer risk in a Chinese
population. Mutagenesis. 27:345–350. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Hedberg Y, Davoodi E, Roos G, Ljungberg B
and Landberg G: Cyclin-D1 expression in human renal-cell carcinoma.
Int J Cancer. 84:268–272. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Phuoc NB, Ehara H, Gotoh T, et al:
Immunohistochemical analysis with multiple antibodies in search of
prognostic markers for clear cell renal cell carcinoma. Urology.
69:843–848. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Allory Y, Matsuoka Y, Bazille C,
Christensen EI, Ronco P and Debiec H: The L1 cell adhesion molecule
is induced in renal cancer cells and correlates with metastasis in
clear cell carcinomas. Clin Cancer Res. 11:1190–1197.
2005.PubMed/NCBI
|
|
29.
|
Migita T, Oda Y, Naito S and Tsuneyoshi M:
Low expression of p27(Kip1) is associated with tumor size and poor
prognosis in patients with renal cell carcinoma. Cancer.
94:973–979. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Bilim V, Kawasaki T, Katagiri A, Wakatsuki
S, Takahashi K and Tomita Y: Altered expression of beta-catenin in
renal cell cancer and transitional cell cancer with the absence of
beta-catenin gene mutations. Clin Cancer Res. 6:460–466.
2000.PubMed/NCBI
|
